Brainsway (BWAY) Share-based Compensation Growth (3y) (2021 - 2026)
Brainsway (BWAY) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | - |
| 10 | Brainsway | 605.04 Mn | 545.27 Mn | 11.68 Mn | 105.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.72% |
| Dec 31, 2025 | -7.32% |
| Sep 30, 2025 | 23.46% |
| Jun 30, 2025 | -17.75% |
| Mar 31, 2025 | -4.57% |
| Dec 31, 2024 | -2.63% |
| Sep 30, 2024 | 3.42% |
| Jun 30, 2024 | -57.58% |
| Mar 31, 2024 | -62.76% |
| Dec 31, 2023 | 22.27% |
| Sep 30, 2023 | -70.35% |
| Jun 30, 2023 | -68.87% |
| Mar 31, 2023 | -26.25% |
| Dec 31, 2022 | 7.77% |
| Sep 30, 2022 | -57.56% |
| Jun 30, 2022 | -53.01% |
| Mar 31, 2022 | -53.00% |
| Dec 31, 2021 | 18.66% |
| Sep 30, 2021 | 16.73% |
| Jun 30, 2021 | 4.47% |